Is there benefit to give additional treatment beyond 4-6 cycles of first line therapy in advanced non-small cell lung cancer (85% of lung cancer in the US)? Watch the video below:
Is there benefit to give additional treatment beyond 4-6 cycles of first line therapy in advanced non-small cell lung cancer (85% of lung cancer in the US)? Watch the video below: